Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer

Clinical Cancer Research

Volumn 16, Issue 8, 2010, Pages 2418-2426

  Saito, Kenichiro ^a,b   Kawakami, Kazuyuki ^a   Matsumoto, Isao ^b   Oda, Makoto ^b   Watanabe, Go ^b   Minamoto, Toshinari ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADOLESCENT; ADULT; AGED; APC TUMOR GENE; ARTICLE; CANCER STAGING; CANCER TISSUE; CDH13 TUMOR GENE; CONTROLLED STUDY; DISEASE MARKER; DNA METHYLATION; DNA MODIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LINE1 TUMOR GENE; LONG INTERSPERSED REPEAT; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; TUMOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; DNA; DNA METHYLATION; FEMALE; GENES, APC; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; LOSS OF HETEROZYGOSITY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 77950983736     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2819     Document Type: Article

References (49)

1. Suzuki K, Nagai K, Yoshida J, et al. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999;67: 927-932 (Pubitemid 29238276)
2. van Rens MT, de la Riviere AB, Elbers HR, van Den Bosch JM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000;117:374-379
3. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360 (Pubitemid 38101630)
4. Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004;350:1713-1721 (Pubitemid 38501140)
5. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428
6. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002;21:5400-5413 (Pubitemid 34983477)
7. Frigola J, Sole X, Paz MF, et al. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet 2005;14:319-326
8. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999;59:67-70. (Pubitemid 29062958)
9. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000;60:5954-5958
10. Battagli C, Uzzo RG, Dulaimi E, et al. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Res 2003;63:8695-8699 (Pubitemid 38064046)
11. Chen WD, Han ZJ, Skoletsky J, et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005;97:1124-1132 (Pubitemid 41511211)
12. Tang X, Khuri FR, Lee JJ, et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 2000;92: 1511-1516
13. Kawakami K, Brabender J, Lord RV, et al. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 2000;92:1805-1811
14. Brabender J, Usadel H, Danenberg KD, et al. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 2001;20: 3528-3532 (Pubitemid 32619405)
15. Maruyama R, Sugio K, Yoshino I, Maehara Y, Gazdar AF. Hyper-methylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma. Cancer 2004;100:1472-1477 (Pubitemid 38366850)
16. Ota N, Kawakami K, Okuda T, et al. Prognostic significance of p16 (INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis. Anticancer Res 2006;26: 3729-3732 (Pubitemid 44701450)
17. Brock MV, Hooker CM, Ota-Machida E, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008; 358:1118-1128 (Pubitemid 351398486)
18. Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300:455. (Pubitemid 36444319)
19. Gaudet F, Hodgson JG, Eden A, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003;300:489-492 (Pubitemid 36444330)
20. Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 2005;24:7213-7223 (Pubitemid 41679283)
21. Pattamadilok J, Huapai N, Rattanatanyong P, et al. LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Int J Gynecol Cancer 2008;18:711-717 (Pubitemid 352020191)
22. Ogino S, Nosho K, Kirkner GJ, et al. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 2008;100:1734-1738
23. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921. (Pubitemid 32165345)
24. Deininger PL, Moran JV, Batzer MA, Kazazian HH, Jr. Mobile elements and mammalian genome evolution. Curr Opin Genet Dev 2003;13:651-658
25. Weisenberger DJ, Campan M, Long TI, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005; 33:6823-6836 (Pubitemid 41830488)
26. Chalitchagorn K, Shuangshoti S, Hourpai N, et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 2004;23:8841-8846 (Pubitemid 39593298)
27. Iacopetta B, Grieu F, Phillips M, et al. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci 2007;98:1454-1460 (Pubitemid 47241770)
28. Sassaman DM, Dombroski BA, Moran JV, et al. Many human L1 elements are capable of retrotransposition. Nat Genet 1997;16:37-43.
29. Brouha B, Schustak J, Badge RM, et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A 2003;100:5280-5285 (Pubitemid 36542696)
30. Symer DE, Connelly C, Szak ST, et al. Human L1 retrotransposition is associated with genetic instability in vivo. Cell 2002;110:327-338
31. Kazazian HH, Jr., Goodier JL. LINE drive. retrotransposition and genome instability. Cell 2002;110:277-280
32. Choma D, Daures JP, Quantin X, Pujol JL. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data. Br J Cancer 2001;85:14-22. (Pubitemid 32695710)
33. Kronenwett U, Ploner A, Zetterberg A, et al. Genomic instability and prognosis in breast carcinomas. Cancer Epidemiol Biomarkers Prev 2006;15:1630-1635 (Pubitemid 44497097)
34. Walther A, Houlston R, Tomlinson I. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 2008;57:941-950 (Pubitemid 351919529)
35. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
36. Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Watanabe G, Iacopetta B. The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res 2003;9:5860-5865 (Pubitemid 38018068)
37. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-793 (Pubitemid 43980599)
38. R Development Core Team. R: A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2008, ISBN 3-900051-07-0.
39. Santourlidis S, Florl A, Ackermann R, Wirtz HC, Schulz WA. High frequency of alterations in DNA methylation in adenocarcinoma of the prostate. Prostate 1999;39:166-174 (Pubitemid 29203403)
40. Kaneda A, Tsukamoto T, Takamura-Enya T, et al. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci 2004;95:58-64. (Pubitemid 38208408)
41. Estecio MR, Gharibyan V, Shen L, et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2007;2:e399.
42. Daskalos A, Nikolaidis G, Xinarianos G, et al. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer 2009;124:81-87
43. Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leuk Res 2008;32:487-490 (Pubitemid 351308023)
44. Menendez L, Benigno BB, McDonald JF. L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol Cancer 2004;3:12.
45. Kawakami K, Jin M, Saito K, et al. Methylation level of LINE-1 repeats as a prognostic factor for the patients with primary colorectal cancer [abstract 991]. Proc Am Assoc Cancer Res 2008;49:232.
46. Dombroski BA, Mathias SL, Nanthakumar E, Scott AF, Kazazian HH, Jr. Isolation of an active human transposable element. Science 1991; 254:1805-1808
47. Mathias SL, Scott AF, Kazazian HH, Jr., Boeke JD, Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 1991;254:1808-1810 (Pubitemid 21917534)
48. Feng Q, Moran JV, Kazazian HH, Jr., Boeke JD. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996;87:905-916 (Pubitemid 26404289)
49. Schulz WA, Elo JP, Florl AR, et al. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 2002;35:58-65.